Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXVG7I
|
||||
| Drug Name |
5-(3-(4,5-dichloro-1H-imidazol-1-yl)prop-1-ynyl)-4-(neopentylamino)pyrimidine-2-carbonitrile
|
||||
| Synonyms |
CHEMBL408562
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C16H16Cl2N6
|
||||
| Canonical SMILES |
CC(C)(C)CNc1nc(ncc1C#CCn2cnc(Cl)c2Cl)C#N
|
||||
| InChI |
InChI=1S/C16H16Cl2N6/c1-16(2,3)9-21-15-11(8-20-12(7-19)23-15)5-4-6-24-10-22-13(17)14(24)18/h8,10H,6,9H2,1-3H3,(H,20,21,23)
|
||||
| InChIKey |
CZDVMEOSWMPNHD-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.